"Thornton Pavilion is an inpatient facility that is part of Jacobs Medical Center. It was formerly known as Thornton Hospital. The main entrance to Jacobs Medical Center is through Thornton Pavilion and is open at all times. Guest relations representatives are on site from 5 a.m. to 7 p.m. After 7 p.m., please sign in with security."

During the past decade, UCSD Thornton Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 18 clinical trials were completed, i.e. on average, 138.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSD Thornton Hospital" #1 sponsor was "Pfizer" with 11 trials, followed by "University of California, San Diego" with 11 trials sponsored, "Shire" with 3 trials sponsored, "Actelion" with 2 trials sponsored and "GlaxoSmithKline" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSD Thornton Hospital" #1 collaborator was "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Cadence Pharmaceuticals" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Copenhagen University Hospital at Herlev" with 1 trials as a collaborator and "Endo Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "UCSD Thornton Hospital" are "Breast Cancer" (2 trials), "Crohn's Disease" (2 trials), "Foot Surgery" (2 trials), "Pain" (2 trials) and "Postoperative Pain" (2 trials). Many other conditions were trialed in "UCSD Thornton Hospital" in a lesser frequency.

Most popular intervention types in "UCSD Thornton Hospital" are "Drug" (30 trials), "Procedure" (6 trials), "Biological" (4 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Avelumab" (2 trials), "Ambrisentan" (1 trials), "Anti-NGF AB" (1 trials) and "Apremilast 20mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSD Thornton Hospital" are 40 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UCSD Thornton Hospital". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in UCSD Thornton Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UCSD Thornton Hospital, 6 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 3 trials that are defined as “Not Applicable".